Free Radicals cover image

Thiel fellow on how longevity can fix biotech - Lada Nuzhna

Free Radicals

00:00

Balancing modality, delivery and indication risk

Lada outlines two company strategies: repurposing approved drugs for aging or solving big unmet age-disease needs with new modalities.

Play episode from 44:31
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app